NCT01992328

IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Ajou University School of Medicine · Academic / Other
• Sex: All
• Age: 16 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Immunoglobulin G deficiency subtypes in patients with asthma six months once a month intravenous immunoglobulin (400mg/kg/4weeks) infection in treatment-related effect on reducing the frequency of asthma exacerbations appreciate.

Detailed description

Patients Registration •It is required to ensure that the patients meet the inclusion criteria for this clinical trial, are free from any items of exclusion criteria, are explained about the participation in the clinical trial along with the informed consent forms. Procedure •six months once a month intravenous immunoglobulin (400mg/kg/4weeks)

Conditions

• Asthma

Interventions

Type	Name	Description
DRUG	Immune Globulin	6 months once a month intravenous immunoglobulin (400mg/kg/4weeks)

Timeline

• Start date: 2013-12-01
• Primary completion: 2017-01-01
• Completion: 2017-01-01
• First posted: 2013-11-25
• Last updated: 2016-05-02